论文部分内容阅读
我们对非小细胞肺癌的32例支气管镜活检标本和52例手术标本进行性激素受体和单抗Ki67检测,以探索在临床开展肺癌内分泌治疗的意义。结果表明:男性ER阳性率为17.5%女性为58%提示女性肺腺癌比男性肺癌更多地受到雌激素影响。TR阳性率男性为35%女性30%,其中女性患者年龄大多超过50岁提示女性肺癌
We performed sex hormone receptor and monoclonal antibody Ki67 in 32 bronchoscopic biopsy specimens and 52 surgical specimens of non-small cell lung cancer to explore the significance of clinical endocrine lung cancer therapy. The results showed that: Male ER-positive rate was 17.5% Females were 58% suggesting that female lung adenocarcinoma is more affected by estrogen than male lung cancer. The positive rate of TR is 35% for women and 30% for women. Female patients are mostly over the age of 50 suggesting female lung cancer